115. 遺伝性周期性四肢麻痺 Hereditary periodic paralysis Clinical trials / Disease details
臨床試験数 : 1 / 薬物数 : 2 - (DrugBank : 2) / 標的遺伝子数 : 13 - 標的パスウェイ数 : 7
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00839501 (ClinicalTrials.gov) | December 2008 | 5/2/2009 | Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome | Therapeutic Trial of Potassium and Acetazolamide in Andersen-Tawil Syndrome | Andersen-Tawil Syndrome | Dietary Supplement: Potassium;Drug: Acetazolamide | University of Rochester | Office of Rare Diseases (ORD);Rare Diseases Clinical Research Network;National Institute of Neurological Disorders and Stroke (NINDS) | Terminated | 10 Years | N/A | Both | 3 | Phase 1 | United States;United Kingdom |